Quipazine
-
Quipazine
structure -
-
CAS No:
4774-24-7
-
Formula:
C13H15N3
-
Chemical Name:
Quipazine
-
Synonyms:
Quinoline,2-(1-piperazinyl)-;2-(1-Piperazinyl)quinoline;Quipazine;1-(2-Quinolyl)piperazine;1-(2-Quinolinyl)piperazine;2-Piperazinoquinoline
- Categories:
-
CAS No:
Description
2-(1-piperazinyl)quinoline is a member of pyridines and a member of piperazines.|Quipazine is a piperazine-based nonselective serotonin (5-HT) receptor agonist with antidepressant and oxytocic activities. Quipazine targets and binds to serotonin receptors, particularly to the 5HT2A and 5HT3 receptors. Serotonin receptor activation by quipazine may lead to smooth muscle contraction and antidepressant effects.|A pharmacologic congener of serotonin that contracts smooth muscle and has actions similar to those of tricyclic antidepressants. It has been proposed as an oxytocic.
Drug Information
Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) (See all compounds classified as Oxytocics.)|Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)|A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)
2-(1-Piperazinyl)quinoline
Quipazine Use and Manufacturing
To a solution formed by dissolving 4.31 g of anhydrous piperazine in 30 ml of ethylene glycol, 818 mg of 2-chloroquinoline was added, and stirred at 140°C for 2 hours. After cooling, saturated aqueous sodium hydrogencarbonate solution was added, and the system was extracted with chloroform. The organic layer was dried over anhydrous magnesium sulfate and the solvent was distilled off under reduced pressure. The residue was purified on silica gel column chromatography (chloroform: methanol = 2:1) to provide 1.09 g (100percent) of 2-piperazin-1-ylquinoline. A mixture of 2-chloroquinoline (2 g; 0.0122 mole ; 1EQ) and piperazine (10.5 g; 0.122 mole ; 10 eq. ) in DMSO (5 ml) was refluxed for 2h. The reaction mixture was cooled to RT, diluted with H20 (20 mi) and extracted with DCM (3X20ML). The organic phases were combined, dried (NA2SO4) and concentrated in vacuo. The crude product was purified by SPE cartridge (Si, 10G), ELUTING with a gradient of 0 to 1percent of MeOH in DCM affording the title compound (1.42 g; yield 55percent). MS; (ES) m/z: 214.3 [MH+]. C13H15N3 requires 213.28. 'H NMR (300MHZ, CDCI3) 5 : 7.85 (d, 1H), 7.74 (d, 1H), 7.97-7. 45 (t/d, 2H), 7.2 (t, 1 H), 6.9 (d, 1H), 3.67 (t, 4H), 2.98 (t, 4H).A mixture of 2-chloroquinoline (2.0 g, 0.012 mol) and piperazine(2.1 g 0.024 mol) in toluene (15 mL) was refluxed stirring for 6 h.The reaction mixture was placed in an ice bath, diluted with 15 mLof water, acidified with concentrated HCl and filtrated. 40 mL ofwater was added to the filtrate and organic phase was separated.The aqueous phase was washed with ethyl ether and alkalized withsolid NaOH. The solid free base was separated by filtration andcrystallized from the mixture of ethanol and water to give compound(7).The title compound was isolated as a white powder. Yield: 52.2percent1.361 g, m.p. 81e84 C (lit. 81e83 C [23]).Step l0.20 g (2.45 mmol) of piperazine was dissolved in 15 mL of isopropanol in a dried round flask provided with nitrogen gas, 2-chloroquinoline 0.20 g (1.2 mmol) was added thereto, and the mixture was refluxed with stirring for 24 hrs. After adding water thereto, the reaction was extracted with ethyl acetate. The formed organic layer was washed with a saturated NaCl solution, dried over anhydrous magnesium sulfate,
antineoplastic
Computed Properties
Molecular Weight:213.28
XLogP3:1.5
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:3
Rotatable Bond Count:1
Exact Mass:213.126597491
Monoisotopic Mass:213.126597491
Topological Polar Surface Area:28.2
Heavy Atom Count:16
Complexity:225
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
(2E)-3-(1-METHYL-1H-PYRROL-2-YL)ACRYLIC ACID
51485-76-8
-
Benadryl N-oxide hydrochloride
13168-00-8
-
6-CHLORO-3-IODO-IMIDAZO[1,2-A]PYRIDINE
885275-59-2
-
(2-Bromophenyl)diphenylphosphine Formula
62336-24-7
-
1-Morpholinocyclopentene Formula
936-52-7
-
4-[2-(Boc-amino)ethoxy]-benzoic acid Formula
168892-66-8
-
3-amino-5-bromopyridine-2-carboxylic acid Structure
870997-85-6
-
2-Amino-6-methylpyridine Structure
1824-81-3
-
What is 3-Bromo-2-methylthiophene
30319-05-2
-
What is THIOPHEN-2-YLMETHYL-PHOSPHONICACIDDIETHYLESTER
2026-42-8